Rising Pharma Holding, Inc. recalls buPROPion Hydrochloride Extended-Release Tablets
FDA Class II
FDA classified this recall as Class II: the product may cause health problems that are temporary or can be treated; the chance of serious harm is remote.
- Hazard
- Presence of Foreign Tablets/Capsules
- Products
-
- buPROPion Hydrochloride Extended-Release Tablets
- Company
- Rising Pharma Holding, Inc.
- Where it was sold
-
Nationwide within the United States
Nationwide
- Units affected
- 47,976 bottles
- About this recall
- buPROPion Hydrochloride Extended-Release Tablets, USP (XL) 150mg, 30-count bottles, Rx Only, Manufactured for: Rising Pharma Holdings, Inc. East Brunswick, NJ 08816 Manufactured by: Graviti Pharmaceuticals Pvt. Ltd. Telangana - 502307, INDIA, NDC 16571-862-03